Combined Chlamydia and Gonorrhea Assays Achieve 98% Accuracy, Pilot Study Shows
Study revealed Lucira’s testing assays offer a 98% accuracy rate in detecting the two sexually transmitted infections.
Read MorePosted by Andy Lundin | Sep 29, 2022 | Sexually Transmitted Diseases |
Study revealed Lucira’s testing assays offer a 98% accuracy rate in detecting the two sexually transmitted infections.
Read MorePosted by Chris Wolski | Sep 26, 2022 | Prostate |
Sylvester Comprehensive Cancer Center’s Game Changer vehicles are offering PSA screening for prostate cancer.
Read MorePosted by Andy Lundin | Sep 22, 2022 | Covid 19, Diagnostic Technologies |
An engineered CRISPR-based method that finds RNA from SARS-CoV-2 promises to make testing for COVID and other diseases fast and easy.
Read MorePosted by Andy Lundin | Sep 19, 2022 | Covid 19 |
The NIH issued two funding opportunities for diagnostic test manufacturers to develop next gen COVID tests, with a focus on accessibility.
Read MorePosted by Andy Lundin | Sep 8, 2022 | Emerging & Zoonotic Diseases |
The FDA is taking steps to increase monkeypox testing capacity and accessibility nationwide as part of its commitment to address the outbreak.
Read More